CLABSI Prevention With Tissue Adhesive (Cya-No-CLABSI)
Central-line Associated Blood Stream Infections (CLABSI)
About this trial
This is an interventional prevention trial for Central-line Associated Blood Stream Infections (CLABSI) focused on measuring CLABSI, Pediatric, Cardiac intensive care, cyanoacrylate, tissue adhesive
Eligibility Criteria
Inclusion Criteria: All patients admitted to pediatric cardiac ICU (PCICU) defined as high-risk for CLABSI (any of): young age<1y & Congenital Heart Surgery Mortality Category (STAT\STS-EACTS) score 2-5 Risk Adjustment for Congenital Heart Surgery (RACHS) category ≥3 preoperative length-of-stay (LOS) >7 days preoperative ventilator support presence of a genetic abnormality extracorporeal membrane oxygenation (ECMO) support Exclusion Criteria: Patients with on-going bacteremia patients with pre-existing central-line or peripherally inserted central catheter (PICC) parental refusal to participate.
Sites / Locations
- Schneider's children medical centerRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Tissue adhesive
Control group
Tissue adhesive application at the CVL exit-site, on all CVLs, PICCs during the patient LOS. Regular CLABSI preventive protocol. Regular preventive CVL dressings (Chlorhexidine >2mo).
Regular CLABSI preventive protocol. Regular preventive CVL dressings (Chlorhexidine >2mo).